Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Personalized medicine Stories

2013-11-14 08:33:06

Findings further demonstrate the validity of a multiple-technology approach to tumor profiling for cancer patients IRVING, Texas, Nov. 14, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present five tumor profiling studies at the 2013 Annual Meeting of the Association for Molecular Pathology (AMP), held this week in Phoenix, Ariz. Results were obtained using Caris' comprehensive tumor profiling...

2013-11-13 12:27:06

Company Attributes its 32,031 Percent Revenue Growth to Innovation and Focus FRAMINGHAM, Mass., Nov. 13, 2013 /PRNewswire/ -- Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, today announced it ranked eight on Deloitte's Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, and clean...

2013-11-13 08:29:29

PHOENIX, Arizona, REDWOOD CITY, California and HILDEN, Germany, November 13, 2013 /PRNewswire/ -- - New web-based product delivers fast and high-confidence interpretation and reporting of variants from next-generation sequencing data for molecular pathologists and medical geneticists - Early access program of clinical interpretation and reporting solution will conclude by year-end, paving the way for early 2014 launch of...

2013-11-12 08:36:54

Molecular diagnostics company launches for full-service CLIA LDT menu BUFFALO, N.Y., Nov. 12, 2013 /PRNewswire/ -- Empire Genomics, LLC (www.empiregenomics.com), an emerging molecular diagnostics company in the field of personalized medicine, announced today that its clinical laboratory facility has met the rigorous standards and obtained approval by the New York State Department of Health, and is now fully licensed (#PFI 8680) in Cytogenetics-Cancer. Simultaneously, Empire Genomics'...

2013-11-08 08:27:30

- Advanced Cell Diagnostic expands RNAscope® technology access through CLIA Service Provider Program HAYWARD, Calif., Nov. 8, 2013 /PRNewswire/ -- Advanced Cell Diagnostics, Inc., a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, today announced that it has introduced a CLIA Certified RNAscope Service Provider program, with Genoptix BioPharma Services, as the first to be certified. This program is designed to support clinical...

2013-11-06 12:29:07

DUBLIN, November 6, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/vqj3bn/epigenetics) has announced the addition of the "Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)" [http://www.researchandmarkets.com/research/vqj3bn/epigenetics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2013-11-05 12:28:52

TUCSON, Ariz., Nov. 5, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with Incyte Corporation to collaborate on the development of companion diagnostic tests for Incyte's oncology drug programs, beginning with the Incyte IDO1 inhibitor program. As part of the agreement, Ventana will support Incyte's personalized medicine healthcare strategies for cancer drug development using its vast...

2013-11-04 23:18:49

Reportbuyer.com just published a new market research report: Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis. London (PRWEB) November 04, 2013 Global Molecular Diagnostics Market & Future Forecast to 2017 Overview The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness...

2013-11-04 16:28:44

MASON, Ohio, Nov. 4, 2013 /PRNewswire/ -- Assurex Health, a leading personalized medicine company, announced today the release of GeneSight(®) MTHFR, the latest addition to its pharmacogenomic test panel. GeneSight MTHFR determines the alleles at the C677T polymorphism in the MTHFR gene to predict effects on folic acid conversion. An individual's genetic inability to convert folic acid into l-methylfolate has been linked to higher incidence of depression. (Logo:...

2013-11-04 15:26:36

As one of the most influential and fruitful annual conference in "Omics", the 8th International Conference on Genomics (ICG-8) was successfully concluded on November 1st with numerous updates provided on on-going research applying today's accurate and affordable technologies to advancing human health and agricultural breeding. The three-day conference, co-organized by BGI and GigaScience Journal, also provided an excellent platform for deeply discussing the challenges and opportunities...